New Micro-Simulation Study in Cancer Medicine Finds Epi proColon® Provides Clinically Meaningful Reductions in Incidence and Mortality of Colorectal Cancer


You May Also Like

Molecular Templates, Inc. Reports First Quarter 2018 Financial Results

MT-3724 Phase Ib Ongoing; Combination Studies Expected to Start in 2H18 AUSTIN, Texas, May ...

Onxeo Introduces platON™, a Proprietary Chemistry Platform of Decoy Oligonucleotides

PlatON™ will generate new best-in-class DNA-targeting drug candidates starting in 2018In parallel, the Company ...